Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis.

Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N, Gross KW, Vivanco Md, Wijendran V, Shioda T, Sgroi D, Donahoe PK, Maheswaran S.

Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1100-5. doi: 10.1073/pnas.0912710107. Epub 2009 Dec 28.

2.

HOXB9 expression promoting tumor cell proliferation and angiogenesis is associated with clinical outcomes in breast cancer patients.

Seki H, Hayashida T, Jinno H, Hirose S, Sakata M, Takahashi M, Maheswaran S, Mukai M, Kitagawa Y.

Ann Surg Oncol. 2012 Jun;19(6):1831-40. doi: 10.1245/s10434-012-2295-5. Epub 2012 Mar 7.

PMID:
22396001
3.

HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.

Wilson CA, Cajulis EE, Green JL, Olsen TM, Chung YA, Damore MA, Dering J, Calzone FJ, Slamon DJ.

Breast Cancer Res. 2005;7(6):R1058-79. Epub 2005 Nov 8.

4.

Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.

Boldrini L, Gisfredi S, Ursino S, Lucchi M, Mussi A, Basolo F, Pingitore R, Fontanini G.

Lung Cancer. 2005 Dec;50(3):309-17. Epub 2005 Aug 24.

PMID:
16125276
5.

The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.

Krupski T, Harding MA, Herce ME, Gulding KM, Stoler MH, Theodorescu D.

Growth Factors. 2001;18(4):287-302.

PMID:
11519827
6.

Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.

Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Dec 3;279(49):51630-46. Epub 2004 Sep 7.

7.

Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication.

Hoshino Y, Hayashida T, Hirata A, Takahashi H, Chiba N, Ohmura M, Wakui M, Jinno H, Hasegawa H, Maheswaran S, Suematsu M, Kitagawa Y.

Mol Cancer. 2014 May 5;13:102. doi: 10.1186/1476-4598-13-102.

8.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
9.

An E2F1-HOXB9 transcriptional circuit is associated with breast cancer progression.

Zhussupova A, Hayashida T, Takahashi M, Miyao K, Okazaki H, Jinno H, Kitagawa Y.

PLoS One. 2014 Aug 19;9(8):e105285. doi: 10.1371/journal.pone.0105285. eCollection 2014.

10.

Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.

Moore LD, Isayeva T, Siegal GP, Ponnazhagan S.

Clin Cancer Res. 2008 Aug 1;14(15):4961-70. doi: 10.1158/1078-0432.CCR-07-4604.

11.
12.

Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.

Fontanini G, Boldrini L, Calcinai A, Chinè S, Lucchi M, Mussi A, Angeletti CA, Basolo F, Bevilacqua G.

Clin Cancer Res. 1999 Jan;5(1):155-61.

14.

Homeodomain-containing protein HOXB9 regulates expression of growth and angiogenic factors, facilitates tumor growth in vitro and is overexpressed in breast cancer tissue.

Shrestha B, Ansari KI, Bhan A, Kasiri S, Hussain I, Mandal SS.

FEBS J. 2012 Oct;279(19):3715-26. doi: 10.1111/j.1742-4658.2012.08733.x. Epub 2012 Aug 31.

15.

Regulation of heparanase gene expression by estrogen in breast cancer.

Elkin M, Cohen I, Zcharia E, Orgel A, Guatta-Rangini Z, Peretz T, Vlodavsky I, Kleinman HK.

Cancer Res. 2003 Dec 15;63(24):8821-6.

16.

Progestin regulation of vascular endothelial growth factor in human breast cancer cells.

Hyder SM, Murthy L, Stancel GM.

Cancer Res. 1998 Feb 1;58(3):392-5.

17.

Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis.

Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K, Frazier WA, Roberts DD, Steeg PS.

Cancer Res. 1994 Dec 15;54(24):6504-11.

18.

Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.

Shoji M, Hancock WW, Abe K, Micko C, Casper KA, Baine RM, Wilcox JN, Danave I, Dillehay DL, Matthews E, Contrino J, Morrissey JH, Gordon S, Edgington TS, Kudryk B, Kreutzer DL, Rickles FR.

Am J Pathol. 1998 Feb;152(2):399-411. Review.

19.

[Expression of vascular endothelial growth factor and its receptor (Flt-1) in breast carcinoma].

Wu H, Li Y, Zhu G, Zhang L, Zhang X, He X.

Zhonghua Yi Xue Za Zhi. 2002 May 25;82(10):708-11. Chinese.

PMID:
12133473
20.

Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.

Lee YK, So IS, Lee SC, Lee JH, Lee CW, Kim WM, Park MK, Lee ST, Park DY, Shin DY, Park CU, Kim YS.

J Gene Med. 2005 Feb;7(2):145-57.

PMID:
15546163

Supplemental Content

Support Center